Cargando…
iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis
Objectives: Fibrosis is a hallmark of systemic sclerosis (SSc), an intractable disease where innovative strategies are still being sought. Among novel anti-fibrotic approaches, mesenchymal stromal/stem cell (MSC)-based therapy appears promising. Previously, we reported anti-fibrotic effects of MSC i...
Autores principales: | Maria, Alexandre T. J., Rozier, Pauline, Fonteneau, Guillaume, Sutra, Thibault, Maumus, Marie, Toupet, Karine, Cristol, Jean-Paul, Jorgensen, Christian, Guilpain, Philippe, Noël, Danièle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308989/ https://www.ncbi.nlm.nih.gov/pubmed/30622540 http://dx.doi.org/10.3389/fimmu.2018.03056 |
Ejemplares similares
-
Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis
por: Rozier, Pauline, et al.
Publicado: (2021) -
Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells
por: Maria, Alexandre T. J., et al.
Publicado: (2018) -
Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
por: Rozier, Pauline, et al.
Publicado: (2021) -
Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
por: Rozier, Pauline, et al.
Publicado: (2018) -
Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology
por: Maumus, Marie, et al.
Publicado: (2011)